Solid tumour oncologists will now have to get used to tongue twisters like "Izalontamab Brengitecan" like heamtologists pronouncing "Axicabtagene ciloleucel"

Nirmal Raut· @oncologician · X·2026-10-27 11:56· 1 天前评分45

正文 · 原文

Solid tumour oncologists will now have to get used to tongue twisters like "Izalontamab Brengitecan" like heamtologists pronouncing "Axicabtagene ciloleucel"
#ESMO2026 @BalazsHalmosMD

16 浏览 · 0 赞 · 0 转发 · 0 回复

会议摘要

2575PNCT06838273 NCT06838273 NCT06838273按 NSCLC, locally advanced 对上

Phase II study of izalontamab brengitecan (Iza-bren) plus osimertinib in patients with EGFR mutant locally advanced or metastatic non-small cell lung cancer (NSCLC)

https://esmocongress.esmo.org

LBA50按 Proffered paper 1: Breast cancer, early and advanced stage 对上

PANKU-Breast01: Randomized phase III study of izalontamab brengitecan (iza-bren) in previously treated unresectable locally advanced or metastatic (LA/M) hormone receptor-positive/HER2-negative (HR+/HER2-) breast cancer (BC)

https://esmocongress.esmo.org

来源：Nirmal Raut · x.com